Literature DB >> 19430207

Cancer cell death by design: apoptosis, autophagy and glioma virotherapy.

Matthew A Tyler1, Ilya V Ulasov, Maciej S Lesniak.   

Abstract

Autophagy has been defined as a mechanism by which oncolytic adenoviruses mediate cell killing in some cancers, including malignant glioma. Until recently, however, adenovirus replication was regarded as a process that induced classical apoptosis in the infected cell. We have assessed the method of conditionally replicating adenovirus (CRAd) death in a model of malignant glioma, considering both autophagy and apoptosis as possible mechanisms of virally-induced cell death. Our initial investigations indicated that autophagy was the predominant system in CRAd-induced cell death in glioma. This appeared to be the case in vitro; however, further investigation in vivo shows that CRAds are capable of inducing both apoptotic and autophagic cell death. In this punctum, we summarize our latest research to uncover the method of oncolytic adenovirus-induced cell death in malignant glioma. Elucidating the relationship between autophagy and apoptosis in glioma virotherapy has significant implications for the design of optimal viral vectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430207     DOI: 10.4161/auto.8792

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  10 in total

1.  E2F-1 lacking the transcriptional activity domain induces autophagy.

Authors:  Aracely Garcia-Garcia; Humberto Rodriguez-Rocha; Michael T Tseng; Roberto Montes de Oca-Luna; H Sam Zhou; Kelly M McMasters; Jorge G Gomez-Gutierrez
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

2.  Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.

Authors:  Jorge G Gomez-Gutierrez; Jonathan Nitz; Rajesh Sharma; Stephen L Wechman; Eric Riedinger; Elvis Martinez-Jaramillo; Heshan Sam Zhou; Kelly M McMasters
Journal:  Virology       Date:  2015-11-09       Impact factor: 3.616

3.  Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX.

Authors:  Natalya V Kaverina; Zaira G Kadagidze; Anton V Borovjagin; Apollon I Karseladze; Chung Kwon Kim; Maciej S Lesniak; Jason Miska; Peng Zhang; Maria A Baryshnikova; Ting Xiao; David Ornelles; Charles Cobbs; Andrey Khramtsov; Ilya V Ulasov
Journal:  Oncogene       Date:  2018-07-10       Impact factor: 9.867

4.  c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells.

Authors:  Ting Sun; DanDan Li; Linlin Wang; LiangPing Xia; JianGuo Ma; Zhong Guan; GongKan Feng; XiaoFeng Zhu
Journal:  J Transl Med       Date:  2011-09-26       Impact factor: 5.531

5.  The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells.

Authors:  Sujan Piya; Erin J White; Sarah R Klein; Hong Jiang; Timothy J McDonnell; Candelaria Gomez-Manzano; Juan Fueyo
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

6.  Oncolytic adenoviruses: A thorny path to glioma cure.

Authors:  I V Ulasov; A V Borovjagin; B A Schroeder; A Y Baryshnikov
Journal:  Genes Dis       Date:  2014-12

Review 7.  Modulating autophagy: a strategy for cancer therapy.

Authors:  Jun-Lin Li; Shao-Liang Han; Xia Fan
Journal:  Chin J Cancer       Date:  2011-10

8.  Autophagy and its link to type II diabetes mellitus.

Authors:  Jai-Sing Yang; Chi-Cheng Lu; Sheng-Chu Kuo; Yuan-Man Hsu; Shih-Chang Tsai; Shih-Yin Chen; Yng-Tay Chen; Ying-Ju Lin; Yu-Chuen Huang; Chao-Jung Chen; Wei-De Lin; Wen-Lin Liao; Wei-Yong Lin; Yu-Huei Liu; Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2017-06-14

9.  Adenovirus early region 3 RIDα protein limits NFκB signaling through stress-activated EGF receptors.

Authors:  Xuehuo Zeng; Cathleen R Carlin
Journal:  PLoS Pathog       Date:  2019-08-19       Impact factor: 6.823

10.  Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.

Authors:  Rodolfo Garza-Morales; Roxana Gonzalez-Ramos; Akiko Chiba; Roberto Montes de Oca-Luna; Lacey R McNally; Kelly M McMasters; Jorge G Gomez-Gutierrez
Journal:  Cancers (Basel)       Date:  2018-05-17       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.